Cargando…
Mediation and longitudinal analysis to interpret the association between clozapine pharmacokinetics, pharmacogenomics, and absolute neutrophil count
Clozapine is effective at reducing symptoms of treatment-resistant schizophrenia, but it can also induce several adverse outcomes including neutropenia and agranulocytosis. We used linear mixed-effect models and structural equation modelling to determine whether pharmacokinetic and genetic variables...
Autores principales: | Lock, Siobhan K., Legge, Sophie E., Kappel, Djenifer B., Willcocks, Isabella R., Helthuis, Marinka, Jansen, John, Walters, James T. R., Owen, Michael J., O’Donovan, Michael C., Pardiñas, Antonio F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585000/ https://www.ncbi.nlm.nih.gov/pubmed/37853043 http://dx.doi.org/10.1038/s41537-023-00404-6 |
Ejemplares similares
-
Clozapine Metabolism is Associated With Absolute Neutrophil Count in Individuals With Treatment-Resistant Schizophrenia
por: Willcocks, Isabella R., et al.
Publicado: (2021) -
The effect of COVID-19 on absolute neutrophil counts in patients
taking clozapine
por: Gee, Siobhan, et al.
Publicado: (2020) -
Reasons for discontinuing clozapine: A cohort study of patients commencing treatment
por: Legge, Sophie E., et al.
Publicado: (2016) -
Reduction in Absolute Neutrophil Counts in Patient on Clozapine Infected with COVID-19
por: Ramli, Fitri Fareez, et al.
Publicado: (2021) -
Genetics of clozapine-associated neutropenia: recent advances, challenges and future perspective
por: Legge, Sophie E, et al.
Publicado: (2019)